-
Something wrong with this record ?
Carbon dioxide insufflation during colonoscopy in inflammatory bowel disease patients: a double-blind, randomized, single-center trial
P. Falt, V. Šmajstrla, P. Fojtík, M. Hill, O. Urban,
Language English Country England, Great Britain
Document type Journal Article, Randomized Controlled Trial
- MeSH
- Abdominal Pain etiology MeSH
- Time Factors MeSH
- Crohn Disease diagnosis pathology MeSH
- Adult MeSH
- Double-Blind Method MeSH
- Flatulence etiology MeSH
- Hypnotics and Sedatives administration & dosage MeSH
- Insufflation adverse effects methods MeSH
- Colon pathology MeSH
- Colonoscopy adverse effects methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Carbon Dioxide administration & dosage adverse effects MeSH
- Predictive Value of Tests MeSH
- Colitis, Ulcerative diagnosis pathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
- Geographicals
- Czech Republic MeSH
OBJECTIVE: Bowel distension by insufflated air causes abdominal discomfort after colonoscopy. Carbon dioxide (CO2) instead of air insufflation during colonoscopy can reduce postprocedural discomfort in diagnostic and screening cases. Discomfort after colonoscopy and CO2 insufflation have never been studied in inflammatory bowel disease (IBD) patients, characterized by younger age, structural changes of the colon, and need for repeated and frequently uncomfortable colonoscopies. Our trial was designed to evaluate postprocedural discomfort associated with CO2 compared with air insufflation in unsedated or minimally sedated patients with known IBD. METHODS: In a double-blind, randomized, single-center study, 64 patients were randomized to either CO2 insufflation (CO2) or air insufflation colonoscopy (Air). Abdominal pain, bloating, and flatulence scores during 24 h after colonoscopy were recorded using a continuous scale of 0-10 (0=none, 10=maximum discomfort). The primary endpoint used for power calculation was bloating score at 1 h after colonoscopy. RESULTS: Pain, bloating, and flatulence scores at end, 1, and 3 h after colonoscopy were significantly lower in CO2 than in Air arm (P<0.001). Scores at 6, 12, and 24 h were comparable. Procedural parameters such as cecal and terminal ileum intubation rate, intubation and total time, pain during insertion, need for repositioning, and abdominal compression were not different between arms. No complications were recorded in the study. CONCLUSION: Compared with air, CO2 insufflation significantly reduces abdominal pain, bloating, and flatulence scores during at least 3 h after colonoscopy in IBD patients, achieving comparable intraprocedural outcomes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031293
- 003
- CZ-PrNML
- 005
- 20171030121627.0
- 007
- ta
- 008
- 171025s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MEG.0000000000000791 $2 doi
- 035 __
- $a (PubMed)27845950
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Falt, Přemysl $u aDigestive Diseases Center, Vítkovice Hospital bDepartment of Internal Medicine, Faculty of Medicine, University of Ostrava, Ostrava cInstitute of Endocrinology, Prague, Czech Republic.
- 245 10
- $a Carbon dioxide insufflation during colonoscopy in inflammatory bowel disease patients: a double-blind, randomized, single-center trial / $c P. Falt, V. Šmajstrla, P. Fojtík, M. Hill, O. Urban,
- 520 9_
- $a OBJECTIVE: Bowel distension by insufflated air causes abdominal discomfort after colonoscopy. Carbon dioxide (CO2) instead of air insufflation during colonoscopy can reduce postprocedural discomfort in diagnostic and screening cases. Discomfort after colonoscopy and CO2 insufflation have never been studied in inflammatory bowel disease (IBD) patients, characterized by younger age, structural changes of the colon, and need for repeated and frequently uncomfortable colonoscopies. Our trial was designed to evaluate postprocedural discomfort associated with CO2 compared with air insufflation in unsedated or minimally sedated patients with known IBD. METHODS: In a double-blind, randomized, single-center study, 64 patients were randomized to either CO2 insufflation (CO2) or air insufflation colonoscopy (Air). Abdominal pain, bloating, and flatulence scores during 24 h after colonoscopy were recorded using a continuous scale of 0-10 (0=none, 10=maximum discomfort). The primary endpoint used for power calculation was bloating score at 1 h after colonoscopy. RESULTS: Pain, bloating, and flatulence scores at end, 1, and 3 h after colonoscopy were significantly lower in CO2 than in Air arm (P<0.001). Scores at 6, 12, and 24 h were comparable. Procedural parameters such as cecal and terminal ileum intubation rate, intubation and total time, pain during insertion, need for repositioning, and abdominal compression were not different between arms. No complications were recorded in the study. CONCLUSION: Compared with air, CO2 insufflation significantly reduces abdominal pain, bloating, and flatulence scores during at least 3 h after colonoscopy in IBD patients, achieving comparable intraprocedural outcomes.
- 650 _2
- $a bolesti břicha $x etiologie $7 D015746
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a oxid uhličitý $x aplikace a dávkování $x škodlivé účinky $7 D002245
- 650 _2
- $a ulcerózní kolitida $x diagnóza $x patologie $7 D003093
- 650 _2
- $a kolon $x patologie $7 D003106
- 650 _2
- $a kolonoskopie $x škodlivé účinky $x metody $7 D003113
- 650 _2
- $a Crohnova nemoc $x diagnóza $x patologie $7 D003424
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a dvojitá slepá metoda $7 D004311
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a flatulence $x etiologie $7 D005414
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypnotika a sedativa $x aplikace a dávkování $7 D006993
- 650 _2
- $a insuflace $x škodlivé účinky $x metody $7 D007327
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Šmajstrla, Vít
- 700 1_
- $a Fojtík, Petr
- 700 1_
- $a Hill, Martin
- 700 1_
- $a Urban, Ondřej
- 773 0_
- $w MED00001618 $t European journal of gastroenterology & hepatology $x 1473-5687 $g Roč. 29, č. 3 (2017), s. 355-359
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27845950 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171030121716 $b ABA008
- 999 __
- $a ok $b bmc $g 1254886 $s 992320
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 29 $c 3 $d 355-359 $i 1473-5687 $m European journal of gastroenterology & hepatology $n Eur J Gastroenterol Hepatol $x MED00001618
- LZP __
- $a Pubmed-20171025